Le Lézard
Classified in: Science and technology
Subjects: CCA, FVT

TI Chief Financial Officer Rafael Lizardi to speak at Citi investor conference


DALLAS, Aug. 20, 2019 /PRNewswire/ -- Texas Instruments Incorporated (TI) (NASDAQ: TXN) Senior Vice President and Chief Financial Officer Rafael Lizardi will speak at the 2019 Citi Global Technology Conference in New York City on Wednesday, September 4, at 8:45 a.m. Eastern time. Lizardi will field questions from analysts and investors, as well as discuss TI's business outlook and its strategy to address key markets for its analog and embedded processing technologies and how these capabilities position the company for growth.

The audio webcast for the conference can be accessed live through the Investor Relations section (http://www.ti.com/ir) of TI's website. An archived replay will be available on the website after his remarks.  

About Texas Instruments

From connected cars and intelligent homes to self-monitoring health devices and automated factories, Texas Instruments Incorporated (TI) (NASDAQ: TXN) products are at work in virtually every type of electronic system. With operations in more than 30 countries, we engineer, manufacture, test and sell analog and embedded semiconductor chips. Our employees, about 30,000 worldwide, are driven by core values of integrity, innovation and commitment, and work every day to shape the future of technology. Learn more at www.TI.com.

TXN-G

 

SOURCE Texas Instruments Incorporated


These press releases may also interest you

at 07:13
Today, IAR Systems® announces full coverage for the RA Arm® Cortex® microcontrollers (MCUs) from Renesas Electronics Corporation. The complete development toolchain IAR Embedded Workbench® provides powerful code optimizations and comprehensive...

at 07:11
Sapiens International Corporation,  , a leading global provider of software solutions for the insurance industry, and a member of the Formula Group , today announced its financial results for the fourth quarter and full year ended December 31, 2019....

at 07:10
ReadCoor, Inc., a company leading true multi-omic spatial sequencing, today unveils its first product line, including multi-omic spatial sequencing assays and the RC2 instrument. The platform is powered by ReadCoor's proprietary FISSEQ (Fluorescent...

at 07:05
F5 today introduced its customer-focused approach to Application Protection, bolstered by new offerings and the company's recent acquisition of Shape Security. Informed by customer use cases, prominent industry attack practices, and threat...

at 07:05
Rocket Pharmaceuticals, Inc. ("Rocket"), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces the recent publication of a peer-reviewed manuscript: the first...

at 07:05
Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that Anthony Johnson, M.D., President and Chief Executive Officer of...



News published on 20 august 2019 at 15:05 and distributed by: